Totem: a case study in HEP

It is being proved that the neurochip \Totem{} is a viable solution for high quality and real time computational tasks in HEP, including event classification, triggering and signal processing. The architecture of the chip is based on a "derivative free" algorithm called Reactive Tabu Search (RTS), highly performing even for low precision weights. ISA, VME or PCI boards integrate the chip as a coprocessor in a host computer. This paper presents: 1) the state of the art and the next evolution of the design of \Totem{}; 2) its ability in the Higgs search at LHC as an example.Comment: Latex, elsart.sty, 5 pages, talk presented by I.Lazzizzera at CHEP97 (Berlin, April 1997

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer

We describe a retrospective series of patients with advanced head-and-neck cancer who were treated with induction chemotherapy followed by radical chemo-radiation. Patients treated with two cycles of induction chemotherapy followed by definitive chemo-radiation for squamous cell carcinoma of the head-and-neck region, from 2001 – 2006 at the Royal Marsden Hospital, formed the basis of this study. Cisplatin (75 mg m−2) on day 1 and 5-FU (1000 mg m−2) day 1 – 4 was the standard regimen used for induction treatment. Cisplatin (100 mg m−2) on day 1 and day 29 was used for concomitant treatment. The radiation was delivered using conformal technique. Tissues containing macroscopic and microscopic disease were treated to doses of 65 Gray (Gy) in 30 fractions and 50 Gy in 25 fractions, respectively. Data on patterns of relapse and acute toxicity (NCICTCv.3.0) were collected. A total of 129 patients were included, median age was 58 (range: 27 – 78). The site of tumour was: oropharynx 70 (54%), larynx 30 (23%), hypopharynx 24 (19%) and other 5 (4%). The median follow-up was 19 months (range: 4 – 58). Local control, disease-specific survival and overall survival at 2 years were 71%, 68% and 63%, respectively. The distant recurrence rate at 2 years was 9%. Ten patients required dose reduction during induction chemotherapy due to toxicity. The dose of 5-FU was reduced in six patients and that of cisplatin in four patients. The incidence of grade 3/4 toxicity was: neutropenia 5%, thrombocytopenia 1%, nausea and vomiting 3%. One cycle of concurrent cisplatin was omitted in 23 patients due to toxicity. Full-dose radiotherapy was administered to 98% of patients. The incidence of grade 3/4 toxicity was: skin 20%, dysphagia 65%, mucositis 60%, neutropenia 3%, anaemia 1%, nausea and vomiting 4%, nephrotoxicity 1%. Induction chemotherapy followed by radical chemo-radiation is a safe and tolerable regimen in the treatment of advanced head-and-neck cancer. Distant recurrence rates are lower with equivalent local control and survival compared to chemo-radiation alone (historical controls)

A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck

<p>Abstract</p> <p>Background</p> <p>Concomitant chemotherapy and radiotherapy (chemoradiation; CRT) is the standard treatment for locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). CRT improves local control and overall survival (OS) when compared to radiotherapy (RT) alone. Induction chemotherapy (IC) reduces the risk of distant metastases (DM) and improves OS by 5% with the use of cisplatin/infusional 5 fluorouracil (PF) in meta-analysis. Adding a taxane to PF in the IC regimen confers a better outcome. Sequential treatment (ST) of IC followed by CRT is therefore under active investigation in multiple phase III trials.</p> <p>Methods</p> <p>We compared the outcome of two cohorts of patients (pts) with LA-SCCHN treated at our institution with CRT (n = 27) or ST (n = 31), respectively. CRT consisted of GEM 100 mg/m²weekly + conventional RT (70 Gy); ST consisted of the same CRT preceded by platinum-based IC.</p> <p>Results</p> <p>Response to IC: complete 8 (26%), partial 20 (65%), stable 1, progressive 1, not evaluable 1. Median follow up of the surviving pts: for CRT 73 months, for ST 51 months. Median time to distant metastasis (TDM) was for CRT 23.6 months, for ST not reached. Median OS was for CRT 20.2 months, for ST 40.2 months. Cox regression analysis, taking into account age, T and N stage and tumor site, showed a hazard ratio with ST of 1.190 for time to locoregional failure (p = 0.712), 0.162 for TDM (p = 0.002), and 0.441 for overall survival (OS) (p = 0.026).</p> <p>Conclusion</p> <p>TDM and OS were found significantly longer in the ST cohort without a reduced locoregional control. Notwithstanding the limitations of a non-randomized single-center comparison, the results are in line with very preliminary data of randomized comparisons suggesting an improved outcome with ST.</p

A Digital Camera for Machine Vision

A prototype of a complete full-frame motion digital camera with grey levels, standard logic interface and software programmability, specifically designed for machine vision applications, is presented. Key to the high integration level of the camera is a monolithic "intelligent" sensor implemented in standard CMOS technology which offers the possibility of integrating signal-conditioning and interface functions on the same die as the sensor array. A highly parallel analogue-to-digital conversion scheme is used to achieve video-rate performance with low power consumption. Applications of the camera in close coupling with the main processors of a number of robotic systems are outline

Smart CMOS Sensor for 3D Measurement

3D measurement is concerned with extracting the three dimensional visual information of an object using a suitable image sensor, aptly called “the electronic eye” for subsequent processing. Advances in microelectronics technologies and intensive research in CMOS image sensors have made it possible to integrate processing circuits on the focal plane of the imager. In this context, a smart image sensor for 3D measurement is proposed for design and development using the industry standard 0.35micron CMOS technology. Preliminary simulation results for finding the centroid of a light spot used in 3D measurement show conformance to the design. The proposal highlights design and implementation of a simple architecture of pixel, a self timing asynchronous clocking mechanism in conjunction with a straightforward digital algorithm to achieve the objective. Early digital approach and ability to choose the number of threshold enable high flexibility of date processing of data processing with sub pixel resolution. The sensor will be the core of an advanced 3D measuring system based on active optical triangulation principl